Cargando…
Deprivation of arginine by recombinant human arginase in prostate cancer cells
BACKGROUND: Recombinant human arginase (rhArg) has been developed for arginine deprivation therapy in cancer, and is currently under clinical investigation. During pre-clinical evaluation, rhArg has exhibited significant anti-proliferative activity in cancer cells deficient in the expression of orni...
Autores principales: | Hsueh, Eddy C, Knebel, Stephanie M, Lo, Wai-Hung, Leung, Yun-Chung, Cheng, Paul Ning-Man, Hsueh, Chung-Tsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403903/ https://www.ncbi.nlm.nih.gov/pubmed/22546217 http://dx.doi.org/10.1186/1756-8722-5-17 |
Ejemplares similares
-
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
por: Tsui, Sam-Mui, et al.
Publicado: (2009) -
Arginase and Arginine Dysregulation in Asthma
por: Benson, Renée C., et al.
Publicado: (2011) -
Recombinant Bacillus caldovelox Arginase Mutant (BCA-M) Induces Apoptosis, Autophagy, Cell Cycle Arrest and Growth Inhibition in Human Cervical Cancer Cells
por: Chung, Sai-Fung, et al.
Publicado: (2020) -
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
por: Matos, Andreia, et al.
Publicado: (2021) -
Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer
por: Xu, Shi, et al.
Publicado: (2018)